Senisca
ID: 7646725SENISCA aims to develop a new generation of oligonucleotide-based interventions, to target the diseases and aesthetic signs of ageing.
1
Funding Rounds
$4.7m
Money raised
Recent Funding Rounds
Overview
SENISCA aims to develop a new generation of oligonucleotide-based interventions, to target the diseases and aesthetic signs of ageing.
- Website:
- Business model: B2B
- Headquarters: Exeter
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Senisca has raised a total of $4.7m in funding over 1 rounds.
Key Insights:
- Senisca March 2024 Seed Funding Round: $4.7m
Industries
Senisca is active in the following industries: